Dr Pallavi Chalasani

Dr. Pallavi Chalasani addresses fertility issues in couples who are anxious to conceive or planning for pregnancy. She provides guidance for those trying for a second pregnancy or facing male factor issues. Her expertise helps patients explore possibilities, including assisted reproductive technologies, tailored to individual needs.

Fibroids, non-cancerous growths in the uterus, are treated by Dr. Pallavi Chalasani with a focus on preserving fertility. She offers solutions ranging from medication to minimally invasive procedures, ensuring minimal impact on a woman’s ability to conceive.

Polycystic Ovary Syndrome (PCOS) affects egg production, leading to ovulation problems. Dr. Pallavi Chalasani provides comprehensive management strategies, including lifestyle modifications and medications, to improve ovulation and increase pregnancy chances.

For women questioning, "Can I get pregnant after tubal canalization or block ?" Dr. Pallavi Chalasani offers hope through diagnostic and therapeutic interventions aimed at restoring tubal patency or recommending alternatives like IVF.

Dr. Pallavi Chalasani deals with premature ovarian insufficiency [which means having less egg count for a given age} by exploring hormonal therapies and fertility preservation techniques to achieve pregnancy.

Endometriosis, characterized by uterine lining tissue outside the uterus, is managed by Dr. Pallavi Chalasani with a combination of medical and surgical options to alleviate symptoms and enhance fertility outcomes.

Adenomyosis involves the invasion of the uterine lining into the uterine wall, causing pain and fertility issues. Dr. Pallavi Chalasani offers treatments, including hormonal therapy and surgery, to improve quality of life and reproductive health

Dr. Pallavi Chalasani evaluates uterine anomalies that may hinder conception or pregnancy maintenance. She provides corrective surgical solutions to optimize the uterine environment for successful pregnancies.

Hydrosalpinx, fluid-filled fallopian tubes, is treated by Dr. Pallavi Chalasani through surgical interventions to remove the blockage or by bypassing the tubes with IVF, enhancing fertility outcomes.

Ovarian cysts can affect fertility, and Dr. Pallavi Chalasani offers a range of treatments from observation to surgical removal, depending on the cyst type and its impact on reproductive health.

For azoospermia, or the absence of sperm, Dr. Pallavi Chalasani collaborates with specialists to explore surgical sperm retrieval or donor options, providing pathways to fatherhood.

Dr. Pallavi Chalasani addresses oligoasthenospermia, a condition of low sperm count and motility, with lifestyle interventions, medications, and assisted reproductive techniques like ICSI to improve conception chances.

Teratozoospermia, involving abnormal sperm shape, is managed by Dr. Pallavi Chalasani through advanced reproductive technologies and personalized treatment plans to enhance fertility prospects.

Ejaculatory dysfunction is treated by Dr. Pallavi Chalasani with medical and behavioral therapies to improve sexual health and fertility outcomes, ensuring a comprehensive approach to male reproductive health.

Dr pallavi chalasani specializes in treating couples facing challenges like RIF / RPL she uses a personalized approach, incorporating advanced diagnostic testing like endometrial receptivity testing, immunological evaluations and tailored embryo transfers with hormone replacement therapies to improve outcomes

Preimplantation genetic testing is a laboratory procedure performed on embryos during an IVF cycle to assess their chromosomal integrity before transfer to the uterus. Embryos are biopsied at the blastocyst stage and analysed for chromosomal abnormalities, structural rearrangements, or specific genetic conditions depending on the type of testing required. Transferring chromosomally normal embryos reduces the risk of implantation failure, miscarriage, and chromosomal conditions in the pregnancy. Dr Pallavi Chalasani incorporates PGT into treatment planning at Fertility by Birthright Rainbow Hospital, Hyder Nagar, Hyderabad, for patients with recurrent IVF failure, recurrent pregnancy loss, advanced maternal age, or a known genetic condition in either partner.

Endometrial Receptivity Analysis is a biopsy-based genomic test that identifies the precise timing of the implantation window for each individual patient, revealing whether the window is pre-receptive, receptive, or post-receptive at the standard transfer time. When the window is displaced, even good-quality embryos transferred at the standard time will not implant, making ERA one of the most clinically significant investigations available for patients with unexplained repeated IVF failure. Dr Pallavi Chalasani uses ERA as part of her structured investigation protocol at Fertility by Birthright Rainbow Hospital, Kukatpally, Hyderabad, ensuring embryo transfers are timed to each patient's individual biology rather than a standard schedule.

Every woman's implantation window is different, and standard embryo transfer protocols are designed for the average patient rather than any specific individual. Endometrial Receptivity Analysis, known as ERA, is a biopsy-based genomic test that determines whether the endometrium is pre-receptive, receptive, or post-receptive at the standard transfer time, identifying a displaced implantation window that would cause even a chromosomally normal embryo to fail. When a displacement is found, the subsequent embryo transfer is adjusted to align precisely with the patient's own receptivity window rather than a standard schedule. Dr. Pallavi Chalasani incorporates ERA into her recurrent IVF failure investigation protocol at Birthright Fertility, Hyder Nagar, Hyderabad, for selected patients with repeated implantation failure despite good-quality embryo transfers, using each patient's individual ERA result to personalise the timing of the embryo transfer and address one of the most commonly overlooked contributors to implantation failure.